Optimal cutoff points for classification in diagnostic studies: new contributions and software development
Por favor, use este identificador para citas ou ligazóns a este ítem:
http://hdl.handle.net/10347/14593
Ficheiros no ítem
Metadatos do ítem
Título: | Optimal cutoff points for classification in diagnostic studies: new contributions and software development |
Autor/a: | López Ratón, Mónica |
Dirección/Titoría: | Cadarso Suárez, Carmen María Molanes López, Elisa María (dir.) |
Outro/a autor/a: | Universidade de Santigo de Compostela. Facultade de Matemáticas. Departamento de Estatística e Investigación Operativa |
Palabras chave: | Biomarker | Diagnostic test | Empirical Likelihood | Generalized Pivotal Quantity | Logistic GAM regression model | Misclassification costs | Optimal threshold | ROC curve | R package | Symmetry point | |
Data: | 2016-04-15 |
Resumo: | Continuous diagnostic tests (biomarkers or risk markers) are often used to discriminate between healthy and diseased populations. For the clinical application of such tests, the key aspect is how to select an appropriate cutpoint or discrimination value c that defines positive and negative test results. In general, individuals with a diagnostic test value smaller than c are classified as healthy and otherwise as diseased. In the literature, several methods have been proposed to select the threshold value c in terms of different specific criteria of optimality. Among others, one of the methods most used in clinical practice is the Symmetry point that maximizes simultaneously both types of correct classifications. From a graphical viewpoint, the Symmetry point is associated to the operating point on the Receiver Operating Characteristic (ROC) curve that intersects the diagonal line passing through the points (0,1) and (1,0). However, this cutpoint is actually valid only when the error of misclassifying a diseased patient has the same severity than the error of misclassifying a healthy patient. Since this may not be the case in practice, an important issue in order to assess the clinical effectiveness of a biomarker is to take into account the costs associated with the decisions taken when selecting the threshold value. Moreover, to facilitate the task of selecting the optimal cut-off point in clinical practice, it is essential to have software that implements the existing optimal criteria in an user-friendly environment. Another interesting issue appears when the marker shows an irregular distribution, with a dominance of diseased subjects in noncontiguous regions. Using a single cutpoint, as common practice in traditional ROC analysis, would not be appropriate for these scenarios because it would lead to erroneous conclusions, not taking full advantage of the intrinsic classificatory capacity of the marker |
URI: | http://hdl.handle.net/10347/14593 |
Dereitos: | Esta obra atópase baixo unha licenza internacional Creative Commons BY-NC-ND 4.0. Calquera forma de reprodución, distribución, comunicación pública ou transformación desta obra non incluída na licenza Creative Commons BY-NC-ND 4.0 só pode ser realizada coa autorización expresa dos titulares, salvo excepción prevista pola lei. Pode acceder Vde. ao texto completo da licenza nesta ligazón: https://creativecommons.org/licenses/by-nc-nd/4.0/deed.gl |
Coleccións
-
- Área de Ciencias [953]
A licenza do ítem descríbese como
Esta obra atópase baixo unha licenza internacional Creative Commons BY-NC-ND 4.0. Calquera forma de reprodución, distribución, comunicación pública ou transformación desta obra non incluída na licenza Creative Commons BY-NC-ND 4.0 só pode ser realizada coa autorización expresa dos titulares, salvo excepción prevista pola lei. Pode acceder Vde. ao texto completo da licenza nesta ligazón: https://creativecommons.org/licenses/by-nc-nd/4.0/deed.gl
Esta obra atópase baixo unha licenza internacional Creative Commons BY-NC-ND 4.0. Calquera forma de reprodución, distribución, comunicación pública ou transformación desta obra non incluída na licenza Creative Commons BY-NC-ND 4.0 só pode ser realizada coa autorización expresa dos titulares, salvo excepción prevista pola lei. Pode acceder Vde. ao texto completo da licenza nesta ligazón: https://creativecommons.org/licenses/by-nc-nd/4.0/deed.gl